Advertisement
Advertisement
Accelerate Diagnostics, Inc. (AXDX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.5611 |
| Open | 0.5700 |
| Bid | 0.4000 x 900 |
| Ask | 0.5700 x 1200 |
| Day's Range | 0.5020 - 0.5956 |
| 52 Week Range | 0.5000 - 9.3600 |
| Volume | |
| Avg. Volume | 541,496 |
| Market Cap | 37.877M |
| Beta (5Y Monthly) | 1.80 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2410 |
| Earnings Date | Feb 21, 2022 - Feb 25, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.00 |
- PR Newswire
Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that Chief Executive Officer, Jack Phillips, will present at the 42nd Annual William Blair Growth Stock Conference on Thursday, June 7, 2022, at 10:00 AM Central Time.
- Zacks
Accelerate Diagnostics (AXDX) Reports Q1 Loss, Tops Revenue Estimates
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 21.88% and 2%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
Accelerate Diagnostics Reports First Quarter 2022 Financial Results
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2022.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
